We are delighted that Dr Manav Pathania and team, who are based at the Milner Therapeutics Institute, have been awarded ~£1 million from Cancer Research UK, to investigate paediatric high-grade gliomas. These rare brain tumours account for less than 20% of brain tumours in children and young people, yet are responsible for the majority of deaths from paediatric cancer in the UK.
Dr Pathania said:
“Current treatments for these childhood brain tumours have life-altering side effects and can only slow down growth of the tumour. By unravelling the mysteries behind these rare tumours, we hope this work will lay the foundations for finding new treatments.”
